ConductScience.org, home

Paper33657293

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.

China L and 10 others. N Engl J Med, 2021. Cited by 275 papers, by iCite.

Cite this record

ConductScience Library. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. Papers, record 33657293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33657293

Download JSON
Disease
cirrhosis of liver189 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
PubMed
Journal
N Engl J Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
275
iCite
Relative citation ratio, by iCite
19.7
iCite
Revised in PubMed
2026-05-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1China LLouise
2Freemantle NNick
3Forrest EEwan
4Kallis YYiannis
5Ryder SDStephen D
6Wright GGavin
7Portal AJAndrew J
8Becares Salles NNatalia
9Gilroy DWDerek W
10O'Brien AAlastair
11ATTIRE Trial InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlbuminsMajor topic
Liver CirrhosisMajor topic
Serum AlbuminMajor topic
Adult
Ascites
Female
Hospitalization
Humans
Infusions, Intravenous
Liver Cirrhosis, Alcoholic
Male
Middle Aged
Pulmonary Edema
Treatment Failure

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06483737Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)Results

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections6

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in33657300Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.https://conductscience.org/library/papers/33657300PubMed
Comment in33753931Searching for therapies for advanced cirrhosis.https://conductscience.org/library/papers/33753931PubMed
Comment in34107190Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.https://conductscience.org/library/papers/34107190PubMed
Comment in34107191Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.https://conductscience.org/library/papers/34107191PubMed
Comment in34107192Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.https://conductscience.org/library/papers/34107192PubMed
Comment in34339226In decompensated cirrhosis, targeted albumin infusions did not improve an in-hospital composite outcome at 15 d.https://conductscience.org/library/papers/34339226PubMed

Download CSV of comments and corrections

Cited by165

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 275 citations.

PMIDTitleJournalYearIn PapersSource
42955590Clinical features and associated factors for porto-sinusoidal vascular disease in primary Sjögren's disease: a retrospective cohort study.Clin Rheumatol2026https://conductscience.org/library/papers/42955590PubMed
42939963Albumin Supplementation Preserves Systemic Antioxidant Defenses in Critically Ill, Septic Patients: A Prospective Comparative Study.Biomedicines2026https://conductscience.org/library/papers/42939963PubMed
42760319A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42760319PubMed
42707863Critical care hepatology: A narrative review of current concepts and management.World J Crit Care Med2026https://conductscience.org/library/papers/42707863PubMed
42581223Albumin in the Management of Hepatorenal Syndrome-Acute Kidney Injury: Is There Ever Too Much?Dig Dis Sci2026https://conductscience.org/library/papers/42581223PubMed
42544300Association of nadir serum albumin during hospitalization with mortality in ICU patients with spontaneous intracerebral hemorrhage.Front Neurol2026https://conductscience.org/library/papers/42544300PubMed
42511757Acute-on-Chronic Liver Failure: An Eroded Cliff Hit by a Storm-A Narrative Review.Int J Mol Sci2026https://conductscience.org/library/papers/42511757PubMed
42435328Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.United European Gastroenterol J2026https://conductscience.org/library/papers/42435328PubMed
42384297Machine learning phenotypes and heterogeneous albumin effects in cirrhotic AKI: a causal inference study.Intern Emerg Med2026https://conductscience.org/library/papers/42384297PubMed
42347089Association of Early Albumin Administration with Clinical Outcomes in Patients Hospitalized with Spontaneous Bacterial Peritonitis: A Propensity-Matched Cohort Study.Reports (MDPI)2026https://conductscience.org/library/papers/42347089PubMed
42292189Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study.Front Med (Lausanne)2026https://conductscience.org/library/papers/42292189PubMed
42194556Factors Associated with Short-Term Clinical Outcomes in ICU Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Single-Center Retrospective Cohort Study.J Clin Med2026https://conductscience.org/library/papers/42194556PubMed
42007477Exploring the prognostic value of serum albumin in critically ill cancer patients: an observational cohort study utilizing machine learning from large intensive care unit databases.JAMIA Open2026https://conductscience.org/library/papers/42007477PubMed
42007297Neutrophil Percentage-to-Albumin Ratio as a Predictor of Urinary Tract Infection in Patients with Urinary Stone Disease: Development a Novel User-Friendly Tool.J Inflamm Res2026https://conductscience.org/library/papers/42007297PubMed
41940988Hypoalbuminemia induces immunosuppression through disorder in macrophages and drives resistance to immune checkpoint inhibitors.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41940988PubMed
41908587Pathogen-Specific Hypoalbuminemia in Patients with Sepsis: A Retrospective Study with Propensity Score Analysis.Infect Drug Resist2026https://conductscience.org/library/papers/41908587PubMed
41889150Low-Dose vs. Standard Care Iv Human Albumin During Large-Volume Paracentesis in Patients With Liver Cirrhosis: A Systematic Review.Liver Int2026https://conductscience.org/library/papers/41889150PubMed
41827398Use of Human Serum Albumin in Critically Ill Patients: A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/41827398PubMed
41753205Nonselective Beta Blockers Are Beneficial in Patients with Cirrhotic Ascites and Spontaneous Bacterial Peritonitis: A Propensity-Matched Study.J Clin Med2026https://conductscience.org/library/papers/41753205PubMed
41733828Not Just for Volume Anymore: New Indications for Albumin in Patients with Liver Disease.Dig Dis Sci2026https://conductscience.org/library/papers/41733828PubMed

See all 165 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Download CSV of genes

Drugs4

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
ALBUMIN HUMANCHEMBL1201451Results1https://conductscience.org/library/drugs/CHEMBL1201451ChEMBL
ARGININECHEMBL1485Results1https://conductscience.org/library/drugs/CHEMBL1485ChEMBL
RIFAXIMINCHEMBL1617Results1https://conductscience.org/library/drugs/CHEMBL1617ChEMBL
LACTULOSECHEMBL296306Results1https://conductscience.org/library/drugs/CHEMBL296306ChEMBL

Download CSV of drugs

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
EudraCT2014-002300-24PubMed
ISRCTN14174793ISRCTN

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33657293

GET https://conductscience.org/api/papers/v1/33657293/cited_by?page=2